Volgende

Automatisch afspelen

Priority Review in Merkel Cell Carcinoma, Breakthrough Designation in RET-Altered Cancers, and More

2 Bekeken • 07/17/23
Delen
insluiten
administrator
administrator
abonnees
0

Gina Columbus reports on a priority review designation in Merkel cell carcinoma, a breakthrough therapy designation in select RET-altered cancers, an application submitted in pediatric ALL, and European approvals in multiple myeloma, melanoma, and ALL.

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen